Sigma-Tau Pharmaceuticals, Inc. Newsroom

The Sigma-Tau Newsroom is the single location to learn latest developments about the company, its research, as well as important discoveries in the understanding and treatment of rare diseases.

News Release – July 22, 2008 - Sigma-Tau Pharmaceuticals, Inc. Supports PhRMA's Code on Interactions with Healthcare Professionals

News Release – July 9, 2008 - Sigma-Tau Pharmaceuticals, Inc. Announces Aquisition of Chenofalk

News Release – April 22, 2008 - Sigma-Tau Pharmaceuticals, Inc. Welcomes Taha Keilani, M.D. as Vice President of Clinical Development

News Release – April 22, 2008 - European Commission Grants Orphan-Drug Designation for Artesunate for the Immediate Treatment of Malaria

News Release – June 22, 2007 - FDA Approves Carnitor SF (Levocarnitine) Sugar-Free Oral Solution For Patients With Carnitine Deficiency

News Release – March 19, 2007 - Walter Reed Army Institute of Research, U.S. Army Medical Materiel Development Activity, and Sigma-Tau Pharmaceuticals, Inc. Announce Collaboration to Investigate New Treatment for Severe Malaria

News Release - January 15, 2007 - Brian Schreiber, M.D. joins Sigma-Tau Pharmaceuticals, Inc. as Vice President of Medical Affairs

Press Release - January 04, 2007 - DOR BioPharma Receives $3 Million From Sigma-Tau Pharmaceuticals for Exclusive Right to Negotiate orBec(R) Strategic Alliance

Press Release - March 30, 2006 - Sigma-Tau strengthens with Banca Intesa (.pdf)